DUBLIN--(BUSINESS WIRE)--The "Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. Kv1.3 Potassium Channel Blockers - Pipeline ...
No. 4 / 2026Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830Single doses of ZP9830 ...
Mutant Brown-Norway-Katholiek (muBN-Ka) rats are capable of producing kininogens in the liver, but cannot release them into the bloodstream, because of the point mutation of Ala163 to Thr in the ...
Researchers at Semmelweis University and University of Szeged have disclosed aminoalkylated benzoxy compounds acting as potassium channel blockers reported to be useful for the treatment of atrial ...
The process of expressing a wide variety of voltage-gated and ligand-gated ion channels enables nociceptors to transduce receptor potential into single action potentials or multiple action potentials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results